Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-16-013270)

Filing Details

Accession Number:: 0001171843-16-013270
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-16 16:01:30
Reporting Period:: 2016-11-15

Filing Date:: 2016-11-16
Accepted Time:: 2016-11-16 16:01:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632778	P Andrew Smith	805 King Farm Blvd, Suite 550 Rockville MD 20850	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Class A	Disposition	2016-11-15	1,766	$15.58	348	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. Shares were sold in multiple transactions at prices ranging from $15.15 to $16.25, inclusive. Upon request the reporting person will provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.